Developing a tool to screen for Hepatitis C in emergency departments
Assessing performance of a Hepatitis C Emergency Department (HepC-END) Screening Tool
['FUNDING_R01'] · UNIVERSITY OF FLORIDA · NIH-10925373
This study is working on a new way to help emergency departments quickly find people who might have Hepatitis C, especially those at higher risk because of opioid use, so they can get diagnosed and treated sooner.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF FLORIDA (nih funded) |
| Locations | 1 site (GAINESVILLE, UNITED STATES) |
| Trial ID | NIH-10925373 on ClinicalTrials.gov |
What this research studies
This research focuses on creating and testing a new screening tool for Hepatitis C virus (HCV) in emergency departments, particularly targeting individuals who may be at high risk due to behaviors associated with the opioid epidemic. The study aims to improve the identification of undiagnosed HCV infections by utilizing an innovative approach that combines artificial intelligence with clinical data. By implementing this tool in emergency settings, the research seeks to enhance the effectiveness of screening programs and ensure that more individuals receive timely diagnosis and treatment for HCV.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals over 21 years old who may be at risk for Hepatitis C, particularly those with a history of injection drug use.
Not a fit: Patients who are not at risk for Hepatitis C or those who have already been diagnosed and treated for the virus may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to earlier detection and treatment of Hepatitis C, significantly improving health outcomes for affected individuals.
How similar studies have performed: Previous research has shown success with emergency department-based screening programs for Hepatitis C, indicating that innovative approaches like this may also yield positive results.
Where this research is happening
GAINESVILLE, UNITED STATES
- UNIVERSITY OF FLORIDA — GAINESVILLE, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: PARK, HAESUK — UNIVERSITY OF FLORIDA
- Study coordinator: PARK, HAESUK
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Acquired Immune Deficiency Syndrome Virus, Acquired Immunodeficiency Syndrome Virus